TABLE 1.
Clinicopathological characteristics of the thymic epithelial tumor patients.
| Total (n = 220) | ||
|---|---|---|
| Gender | Male | 124 (56%) |
| Female | 96 (44%) | |
| Age | Mean ± SD | 59.4 ± 13.4 |
| Myasthenia gravis | Yes | 33 (15%) |
| No | 187 (85%) | |
| Operation | Sternotomy | 132 (60%) |
| Thoracotomy | 54 (25%) | |
| VATS | 13 (6%) | |
| RATS | 21 (9%) | |
| Histology | Thymoma | 163 (74%) |
| Carcinoma | 47 (21%) | |
| Neuroendocrine | 10 (5%) | |
| T Descriptor | 1 | 113 (51%) |
| 2 | 44 (20%) | |
| 3 | 43 (20%) | |
| 4 | 20 (9%) | |
| N descriptor | 0 | 201 (91%) |
| 1 | 14 (6%) | |
| 2 | 5 (2%) | |
| TNM stage | I | 113 (51%) |
| II | 43 (20%) | |
| III | 35 (16%) | |
| IV | 29 (13%) | |
| WHO | A | 26 (12%) |
| AB | 55 (25%) | |
| B1 | 46 (21%) | |
| B2 | 26 (12%) | |
| B3 | 10 (4%) | |
| C | 57 (26%) | |
| Masaoka-Koga | 1 | 112 (51%) |
| 2 | 47 (22%) | |
| 3 | 32 (14%) | |
| 4 | 29 (13%) |